CAS 73963-72-1: Cilostazol
Formula:C20H27N5O2
InChI:InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)
InChI key:InChIKey=RRGUKTPIGVIEKM-UHFFFAOYSA-N
SMILES:C(CCCOC=1C=C2C(=CC1)NC(=O)CC2)C=3N(N=NN3)C4CCCCC4
Synonyms:- 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-
- 6-[4-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
- 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
- 6-[4-(1-Cyclohexyl-5-Tetrazolyl)Butoxy]-1,2,3,4-Tetrahydro-2-Oxoquinolinone
- 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
- Cilostazole
- Opc 13013
- Opc 21
- Pletaal
- Pletal
- Cilostazol
Sort by
Found 16 products.
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
CAS:6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-oneColor and Shape:SolidMolecular weight:369.46g/molCilostazol
CAS:Lactams not elsewhere specified or includedFormula:C20H27N5O2Color and Shape:White Off-White Crystalline PowderMolecular weight:369.21648Cilostazol
CAS:Formula:C20H27N5O2Purity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:369.476-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
CAS:Cilostazol is a drug that binds to ATP-binding cassette (ABC) transporters, which are proteins that transport molecules across membranes. It decreases the production of cyclic nucleotides and phosphodiesterase, which are important in the regulation of blood vessel tone. Cilostazol has been shown to be effective in treating heart failure and atherosclerosis. Cilostazol also inhibits cyclase activity, an enzyme involved in the synthesis of cyclic nucleotides, which leads to vasodilation by increasing the concentration of cAMP. The drug is available in both immediate-release and controlled-release preparations. Cilostazol can have serious side effects such as congestive heart failure or stroke if it is taken with other drugs that inhibit platelet aggregation such as aspirin or warfarin.Formula:C20H27N5O2Purity:Min. 95%Color and Shape:White PowderMolecular weight:369.46 g/molCilostazol
CAS:Controlled ProductApplications A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogenic, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo. Neuroprotective & Neuroresearch product. References Suri, A., et al.: J. Clin. Pharmacol., 38, 144 (1998), Park, S.-W., et al.: Am. J. Cardiol., 84, 511 (1999), Tsuchikane, E., et al.: Circulation, 100, 21 (1999),Formula:C20H27N5O2Color and Shape:NeatMolecular weight:369.46Cilostazol
CAS:Cilostazol (OPC 21) is a Phosphodiesterase 3 Inhibitor. The mechanism of action of cilostazol is as a Phosphodiesterase 3 Inhibitor.Formula:C20H27N5O2Purity:99.58% - 99.90%Color and Shape:Off-White SolidMolecular weight:369.46Cilostazol
CAS:CilostazolFormula:C20H27N5O2Purity:99% (Typical Value in Batch COA)Color and Shape: white powderMolecular weight:369.46g/molCilostazol
CAS:Formula:C20H27N5O2Purity:≥ 98.0%Color and Shape:White to off-white powder or crystalsMolecular weight:369.46
![6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F54%2Fthumb%2FOR13681.jpg&w=3840&q=75)
![6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FFC03161.jpg&w=3840&q=75)
